NCT06574828View on ClinicalTrials.gov

A Study to Find Out How Multiple Doses of BIIB091 Affect the Electrical Activity of the Heart in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

August 29, 2024

Primary Completion Date

March 22, 2025

Study Completion Date

March 22, 2025

Conditions
Healthy Volunteer
Interventions
DRUG

BIIB091

Administered as specified in the treatment arm.

DRUG

Moxifloxacin

Administered as specified in the treatment arm.

DRUG

BIIB091-matched Placebo

Administered as specified in the treatment arm.

DRUG

Moxifloxacin-matched Placebo

Administered as specified in the treatment arm.

Trial Locations (1)

78744

Austin Clinic PPD, Austin

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT06574828 - A Study to Find Out How Multiple Doses of BIIB091 Affect the Electrical Activity of the Heart in Healthy Participants | Biotech Hunter | Biotech Hunter